Sepsis Flashcards
Definition
Sepsis
life-threatening organ dysfunction caused by a dysregulated host response to infection
Definitions
Sepsis-3 (2016)
Sepsis
life-threatening organ dysfunction caused by a dysregulated host response to infection
Clinical variables
qSOFA Score
non-ICU patients
SBP ≤ 100
Altered mental status (GCS ≤ 15)
RR ≥ 22
qSOFA >= 2 indicates sepsis
Definition
Sepsis-3 (2016)
Septic shock
Definition: A subset of sepsis in which underlying circulatory/cellular/metabolic abnormalities are profound enough to substantially increase mortality
Clinical criteria
Sepsis-3 (2016)
Septic shock
-
persistant hypotension requiring vasopressors to maintain MAP >= 65 –> cirulatory dysfunction
AND - serum lactate level >2 mmol/L –> cellular dysfunction
Clinical criteria
Sepsis-3 (2016)
Sepsis
2 or more SOFA (ICU patients)
2 or more qSOFA (non-ICU patients)
Clinical values
SOFA Score
ICU patients
PaO2/FiO2
Platelet, bilirubin
MAP (pressor requirements)
Glasgow Coma Scale (GCS)
SCr/UO
2 or more SOFA –> sepsis
Initial resuscitation
Hour-1 Bundle
Elements to be initiated within the first hour
- measure lactate level; re-measure if initial lactate is >2 mmol/L
- Obtain blood cultures prior to administration of antibiotics (aneanerobic AND aerobic)
- Administer braod spectrum abx
- Administer 30mL/kg cystalloid for hypotension ot lactate >= 4 mmol/L
- apply vasopressors if patient is hypotensive during OR after fluid resuscitation to maintain mean arterial pressure >= 65mmHg
Management of Septic Shock
- control infection
- hemodynamic stability
- other supportive measures
Management of Septic Shock
Hemodynamic stability
Fluid resuscitation
Begin immediately (within 1 hr)
- first line: crystalloids 30 mg/kg BOLUS
* NS > LR - colloids
* may consider albumin in addition to crystalloid
* avoid HES
Management of Septic Shock
Hemodynamic stability
Vasopressors - for fluid-refractory hypoperfusion
Goal: MAP of 65
- first-line: norepi
* titrate to MAP - second-line: vasopressin
* can be added to NE up to 0.03u/min IV infusion
* used to rach target MAP or dec NE usage - second-line: epinephrine
* can be added to NE
* titrate to goal MAP
* used to reach target MAP - Dopamine
* alternative to NE ONLY in patients with compromised systolic function and low risk of tachyarrythmias - dobutamine
* use if persistent hypoperfusion despite fluid/vasopressor agents - phenylephrine
* limit use
Management of septic shock: hemodynamic stability
Norepinephrine
Vasopressor, MOA
agonist
a1 > b1
Inc SVR, HR, contractility
Management of septic shock: hemodynamic stability
Epinephrine
Vasopressor, MOA
agonist
b1 > b2 > a1 > a2
Inc HR, contractility
Vasodilation, bronchodilation
Management of septic shock: hemodynamic stability
Vasopressin
Vasopressor, MOA
agonist
V123R
Inc SVR, PVR
Plt aggregation, anti-duiresis
Effective in acidosis
Management of septic shock: hemodynamic stability
Phenylephrine
Vasopressor, MOA
pure a agonist
Inc SVR
No effect on HR or contractility